Trending stocks: Glenmark Pharma shares down nearly 3%

NEW DELHI: Shares of Glenmark Pharmaceuticals Ltd. traded 2.69 per cent down in Wednesday's trade at 09:44AM (IST). Around 418,858 shares changed hands on the counter.

The scrip opened at Rs 450.0 and touched an intraday high and low of Rs 479.9 and Rs 450.0, respectively, in the session so far. Shares of the company of Glenmark Pharmaceuticals Ltd. quoted a 52-week high of Rs 572.7 and a 52-week low of Rs 168.0.

Total market cap of the Glenmark Pharmaceuticals Ltd. stood at Rs 13168.79 crore at the time of writing this report.


Key Financials
The company reported consolidated sales of Rs 2735.56 crore for the quarter ended 31-Dec-2019, down 1.02 per cent from previous quarter's Rs 2763.73 crore and down 9.0 per cent from the year-ago quarter's Rs 2509.78 crore.

The net profit for latest quarter stood at Rs 190.839 crore, up 64.03 per cent from the corresponding quarter last year.

Shareholding pattern
As of 31-Mar-2020, DIIs held 3.74 per cent stake in the company, while foreign institutional investors held 28.51 per cent and the promoters 46.62 per cent.


Valuation ratio
According to BSE data, the stock traded at a price-to-earnings multiple of 18.36 and a price-to-book ratio of 2.35. A higher P/E ratio shows investors are willing to pay a higher price because of better future growth expectations. Price-to-book value indicates the inherent value of a company and is the measure of the price that investors are ready to pay even for no growth in the business.

Glenmark Pharmaceuticals Ltd. belongs to the Pharma - Indian industry.